undamentalytics Newsletter
Sign in

Immunome Inc. revenue

Immunome Inc.'s revenue was $6.9m in fiscal 2025, down 23.2% on the year before. Over the last twelve months it was $0.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue14970
Growth on the year before—−35.5%−23.2%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Immunome Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Immunome Inc.